Liftstream is an executive search recruitment company in the life sciences sector
Biotech clusters are big business. They attract investment, spur innovation and create economic prosperity for the local economy, let alone the bragging rights that come from market superiority. In the United States, Boston in Massachusetts and the Bay Area in California, duke it out annually for the accolade of top life science cluster. Unquestionably though, what is happening in Boston right now is nothing short of remarkable and the gravitational pull of this bioscience ecosystem is attracting companies from across the globe.
When we look at these clusters, we look for the winning formula – the template that will translate ambition into reality, in the way Boston has managed to. How can we emulate that success? Well, the truth is, the success of a bioscience cluster is driven my multiple factors, the more prominent of which are; scientific research, access to capital, investment environment, infrastructure and resources, and human capital.
So while Boston reigns superior and San Francisco tries to regain top spot, we wondered about the other pretenders to the crown. In particular, that of San Diego, a highly ranked cluster (often 3rd) which offers something different from these current ‘super-clusters’.
For this reason, we took a deeper dive into the San Diego biotech cluster and we did so from the knowledge base that we possess, which is human capital and executive leadership. We wanted to look at what public biotechnology companies (44 in total) looked like in terms of their CEO leadership and the board of directors which govern them.
Liftstream Releases Board Director and CEO Compensation and Governance 2015 Report – San Diego Biotechnology Cluster
Executive committee leadership and oversight by experienced and skilled boards will improve performance and governance of the biotechnology companies driving innovation. Understanding the landscape of corporate governance in biotech clusters will help companies evaluate their own boards’ strength.
Trovagene, a cell-free molecular diagnostics company in San Diego, California, has terminated the employment of CEO Antonius Schuh and CFO Stephen Zaniboni for withholding new therapeutics in the field of precision medicine for their own benefit. The firm filed a complaint against Schuh and Zaniboni for breach of fiduciary duty, which was filed in the Superior Court of the State of California for the County of San Diego. The complaint requests Schuh and Zaniboni to turn over their interests in these new therapeutics to Trovagene.
Northwest Biotherapeutics (NW Bio), a biotechnology company developing personalised immunotherapy products based in Bethesda, Maryland, has appointed Susan Bayh and Cofer Black as independent directors.
Nominations Committees’ Resolutions Series: #5 – The Importance of Improving Shareholder Communication
Open and effective communication regarding director appointments, executive committee appointments, succession plans, nomination governance and process, board evaluations, will all boosts transparency and good governance recognition which strengthen shareholders’ trust. Whichever communication approach, nominations committees should reassure shareholders of the sustainability of the board and executive management by disclosing relevant information.live streaming film Underworld: Blood Wars 2016
Any new job requires the appointee to assimilate critical information about how the company is run, what its business is and how the company can benefit from their experience. Non-executive directors are absolutely no different in this regard and company boards need to induct their new members effectively.